Donald Addington1, Sabina Abidi2, Iliana Garcia-Ortega1, William G Honer3, Zahinoor Ismail1. 1. 1 Department of Psychiatry, Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, Alberta. 2. 2 Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia. 3. 3 Department of Psychiatry, University of British Columbia, Vancouver, British Columbia.
Abstract
OBJECTIVE: The objective of this article is to identify best practices in the diagnosis and assessment of patients with schizophrenia spectrum and other psychotic disorders. The diagnosis and assessment may occur in a range of situations from the emergency room to the outpatient clinic and at different stages of the disorder. The focus may be on acute exacerbations of illness, residual symptoms, levels of function, or changes in the response to treatment. METHODS: A systematic search was conducted for guidelines published in the last 5 years for schizophrenia and schizophrenia spectrum disorders. The guidelines were rated by at least 2 raters, and recommendations adopted on the diagnosis and assessment were primarily drawn from the American Psychiatric Association practice guidelines for the psychiatric evaluation of adults and the National Institute for Health and Care Excellence guideline on psychosis and schizophrenia in adults. A number of de novo recommendations were also developed. RESULTS: Eleven recommendations were identified that cover a range of assessment situations from diagnosis to the involvement of families in assessments. CONCLUSIONS: An accurate assessment establishes the baseline for treatment planning based on clinical decision making for both pharmacotherapy and psychosocial treatments.
OBJECTIVE: The objective of this article is to identify best practices in the diagnosis and assessment of patients with schizophrenia spectrum and other psychotic disorders. The diagnosis and assessment may occur in a range of situations from the emergency room to the outpatient clinic and at different stages of the disorder. The focus may be on acute exacerbations of illness, residual symptoms, levels of function, or changes in the response to treatment. METHODS: A systematic search was conducted for guidelines published in the last 5 years for schizophrenia and schizophrenia spectrum disorders. The guidelines were rated by at least 2 raters, and recommendations adopted on the diagnosis and assessment were primarily drawn from the American Psychiatric Association practice guidelines for the psychiatric evaluation of adults and the National Institute for Health and Care Excellence guideline on psychosis and schizophrenia in adults. A number of de novo recommendations were also developed. RESULTS: Eleven recommendations were identified that cover a range of assessment situations from diagnosis to the involvement of families in assessments. CONCLUSIONS: An accurate assessment establishes the baseline for treatment planning based on clinical decision making for both pharmacotherapy and psychosocial treatments.
Entities:
Keywords:
diagnosis; health services research; mental health services; practice guideline; psychiatric status rating scales; schizophrenia spectrum and other psychotic disorder
Authors: Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger Journal: CMAJ Date: 2010-07-05 Impact factor: 8.262
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville Journal: Arch Gen Psychiatry Date: 1992-08
Authors: Sharon R Foley; Brendan D Kelly; Mary Clarke; Orfhlaith McTigue; Maurice Gervin; Moyyad Kamali; Conall Larkin; Eadbhard O'Callaghan; Stephen Browne Journal: Schizophr Res Date: 2005-01-01 Impact factor: 4.939
Authors: Jill M Harkavy-Friedman; David Kimhy; Elizabeth A Nelson; David F Venarde; Dolores Malaspina; J John Mann Journal: J Clin Psychiatry Date: 2003-08 Impact factor: 4.384
Authors: E Albon; A Tsourapas; E Frew; C Davenport; F Oyebode; S Bayliss; T Arvanitis; C Meads Journal: Health Technol Assess Date: 2008-05 Impact factor: 4.014
Authors: Paul Kurdyak; Emilie Mallia; Claire de Oliveira; Andre F Carvalho; Nicole Kozloff; Juveria Zaheer; Wanda M Tempelaar; Kelly K Anderson; Christoph U Correll; Aristotle N Voineskos Journal: Schizophr Bull Date: 2021-04-29 Impact factor: 9.306
Authors: Jessica D'Arcey; Joanna Collaton; Nicole Kozloff; Aristotle N Voineskos; Sean A Kidd; George Foussias Journal: JMIR Ment Health Date: 2020-04-02